NCT02065869 2023-09-29Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell TransplantBellicum PharmaceuticalsPhase 1/2 Terminated187 enrolled 8 charts
NCT03301168 2022-07-12Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantBellicum PharmaceuticalsPhase 1/2 Active not recruiting120 enrolled